Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA) Key Statistics
26 reported figures for Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 10.33B
- P/E (trailing)
- 29.99
- P/B
- 3.54
- Dividend yield (FY 2025)
- 0.59%
Income (latest fiscal year)
- Revenue
- EGP 4.1B
- Net income
- EGP 289.61M
- EBITDA
- EGP 1.03B
- Free cash flow
- EGP -199.57M
- Profit margin
- 7.07%
Balance sheet
- Total assets
- EGP 5.34B
- Total debt
- EGP 2.41B
- Book value
- EGP 2.33B
Growth
- Revenue growth
- 47.94%
- Profit growth
- -24.15%
- EPS growth
- -26.87%
Per share
- EPS (fiscal year)
- 0.13
- Book value per share
- 1.15
- Dividend per share
- 0.03
- Return on equity
- 13.75%
- Return on assets
- 6%
Technical
- RSI (14)
- 44
- 50-day moving average
- EGP 5.72
- 200-day moving average
- EGP 4.83
- Beta (1Y)
- 0.64
Shares
- Shares outstanding
- 2.03B
- Free float
- 67.68%
Fiscal-year figures are as the company last reported them; technical readings refresh with market data.